These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39088085)

  • 1. SGLT1 contributes to glucose-mediated exacerbation of ischemia-reperfusion injury in ex vivo rat heart.
    Almalki A; Arjun S; Harding I; Jasem H; Kolatsi-Joannou M; Jafree DJ; Pomeranz G; Long DA; Yellon DM; Bell RM
    Basic Res Cardiol; 2024 Oct; 119(5):733-749. PubMed ID: 39088085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
    Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
    Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury.
    Li Z; Agrawal V; Ramratnam M; Sharma RK; D'Auria S; Sincoular A; Jakubiak M; Music ML; Kutschke WJ; Huang XN; Gifford L; Ahmad F
    Cardiovasc Res; 2019 Sep; 115(11):1646-1658. PubMed ID: 30715251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.
    Kashiwagi Y; Nagoshi T; Yoshino T; Tanaka TD; Ito K; Harada T; Takahashi H; Ikegami M; Anzawa R; Yoshimura M
    PLoS One; 2015; 10(6):e0130605. PubMed ID: 26121582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury.
    Kanwal A; Nizami HL; Mallapudi S; Putcha UK; Mohan GK; Banerjee SK
    Biochem Biophys Res Commun; 2016 Apr; 472(2):392-8. PubMed ID: 26920054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
    Hausenloy DJ; Whittington HJ; Wynne AM; Begum SS; Theodorou L; Riksen N; Mocanu MM; Yellon DM
    Cardiovasc Diabetol; 2013 Oct; 12():154. PubMed ID: 24148218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein.
    Su H; Ji L; Xing W; Zhang W; Zhou H; Qian X; Wang X; Gao F; Sun X; Zhang H
    J Cell Mol Med; 2013 Jan; 17(1):181-91. PubMed ID: 23305039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin Protects Against Myocardial Ischemia/Reperfusion Injury via Activation of RISK (Reperfusion Injury Salvage Kinase) and SAFE (Survivor Activating Factor Enhancement) Pathways.
    Yang X; Yue R; Zhang J; Zhang X; Liu Y; Chen C; Wang X; Luo H; Wang WE; Chen X; Wang HJ; Jose PA; Wang H; Zeng C
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
    Lieder HR; Braczko F; Gedik N; Stroetges M; Heusch G; Kleinbongard P
    Basic Res Cardiol; 2021 Apr; 116(1):27. PubMed ID: 33876304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric Oxide/Glucose Transporter Type 4 Pathway Mediates Cardioprotection against Ischemia/Reperfusion Injury under Hyperglycemic and Diabetic Conditions in Rats.
    Al-Kouh A; Babiker F
    J Vasc Res; 2024; 61(4):179-196. PubMed ID: 38952123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA nuclear-enriched abundant transcript 1 inhibition blunts myocardial ischemia reperfusion injury via autophagic flux arrest and apoptosis in streptozotocin-induced diabetic rats.
    Ma M; Hui J; Zhang QY; Zhu Y; He Y; Liu XJ
    Atherosclerosis; 2018 Oct; 277():113-122. PubMed ID: 30205319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia-reperfusion injury: a meta-analysis.
    Sayour AA; Celeng C; Oláh A; Ruppert M; Merkely B; Radovits T
    Diabetologia; 2021 Apr; 64(4):737-748. PubMed ID: 33483761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin-Mediated Cardiac Protection From Ischemia/Reperfusion Injury in Diabetic Rats Is Associated With Endothelial Nitric Oxide Synthase/Glucose Transporter-4 Signaling Pathway.
    Babiker F; Al-Kouh A
    J Cardiovasc Pharmacol; 2024 Sep; 84(3):319-330. PubMed ID: 39240727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts.
    Uthman L; Nederlof R; Eerbeek O; Baartscheer A; Schumacher C; Buchholtz N; Hollmann MW; Coronel R; Weber NC; Zuurbier CJ
    Cardiovasc Res; 2019 Aug; 115(10):1533-1545. PubMed ID: 30649212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.
    Kristiansen SB; Pælestik KB; Johnsen J; Jespersen NR; Pryds K; Hjortbak MV; Jensen RV; Bøtker HE
    Cardiovasc Diabetol; 2019 May; 18(1):66. PubMed ID: 31151453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of lethal ischemia/reperfusion injury in rat hearts subjected to ischemic preconditioning is increased under conditions of simulated hyperglycemia.
    Zálešák M; Blažíček P; Pancza D; Ledvényiová V; Barteková M; Nemčeková M; Čarnická S; Ziegelhöffer A; Ravingerová T
    Physiol Res; 2014; 63(5):577-85. PubMed ID: 24908083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular calcification abrogates the nicorandil mediated cardio-protection in ischemia reperfusion injury of rat heart.
    Ravindran S; Murali J; Amirthalingam SK; Gopalakrishnan S; Kurian GA
    Vascul Pharmacol; 2017 Feb; 89():31-38. PubMed ID: 28087358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.
    Povlsen JA; Løfgren B; Rasmussen LE; Nielsen JM; Nørregaard R; Kristiansen SB; Bøtker HE; Nielsen TT
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):892-8. PubMed ID: 19298538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
    Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
    Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes impairs the protective effects of sevoflurane postconditioning in the myocardium subjected to ischemia/ reperfusion injury in rats: important role of Drp1.
    Yu J; He J; Yang W; Wang X; Shi G; Duan Y; Wang H; Han C
    BMC Cardiovasc Disord; 2021 Feb; 21(1):96. PubMed ID: 33593294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.